(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Founded in 1959 by its current Editor, the series has moved from its initial focus on medicinal chemistry to a much wider scope. Today it encompasses all fields concerned with the development of new therapeutic drugs and the elucidation of their mechanisms of action, reflecting the increasingly complex nature of modern drug research. Invited authors present their biological, chemical, biochemical, physiological, immunological, pharmaceutical, toxicological, pharmacological and clinical expertise in carefully written reviews and provide the newcomer and the specialist alike with an up-to-date comprehensive list of prime references. Each volume of Progress in Drug Research contains fully cross-referencing indices which link the books together, forming a virtually encyclopaedic work. The series thus serves as an important, time-saving source of information for researchers concerned with drug research and all those who need to keep abreast of the many recent developments in the quest for new and better medicines.
Contents:
Alternative medicine: Herbal drugs and their critical appraisal - Part I.- Current and potential therapies for the treatment of herpesvirus infections.- Quantitiative structure-activity relationships of antianginal drugs.- Purine analogs as CDK enzyme inhibitory agents: A survey and QSAR analysis.- Anti-influenza drugs and neuraminidase inhibitors.- Index Vol. 56.- Index of titles, Vol. 1-56.- Author and paper index, Vol. 1-56.
PRODUCT DETAILS
Publisher: Springer (Birkhauser Verlag AG)
Publication date: October, 2012
Pages: 294
Weight: 537g
Availability: Available
Subcategories: General Practice, Pharmacology
From the same series
